Immune checkpoint inhibitors have limited efficacy in SMARCA4-deficient non-small cell lung cancer - Han, Ying; Wang, Jing; Pang, Boyue; Zhang, Jiali; Zhao, Xiaoliang; Hao, Shuan; Zhang, Qiang; Ren, Xiubao; Sun, Leina (Translational Lung Cancer Research; Vol 14, No 11 (November 30, 2025): Translational Lung Cancer Research, 2025)